ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ)
$29.28 -0.94 (-3.1105%)
Analysed ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) News Sources
Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference
03-06-2026
yahoo.com
Ultragenyx (RARE) Down 13.6% Since Last Earnings Report: Can It Rebound?
04-06-2026
yahoo.com
Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE)
05-06-2026
yahoo.com
How The Ultragenyx Pharmaceutical (RARE) Investment Story Is Shifting With New Data And Street Views
06-06-2026
yahoo.com
Here is Why Ultragenyx Pharmaceutical (RARE) is One of the Best Buy-the-Dip Stocks
13-06-2026
yahoo.com
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19-06-2026
yahoo.com
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
23-06-2026
yahoo.com
Ultragenyx (RARE) Soars 5.2%: Is Further Upside Left in the Stock?
29-06-2026
yahoo.com
IONS Completes Enrollment in Pivotal Cohort of Angelman Syndrome Study
07-07-2026
yahoo.com
Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact
08-07-2026
yahoo.com
What is the current price of ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ)?
The current price of ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) is $29.28.
ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) absolute price change since previous trading day?
The absolute price change of ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) since the previous trading day is $-0.94.
ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) percentage price change since previous trading day?
The percentage price change of ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) since the previous trading day is -3.1105%.
What is the most recent average sentiment score for ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ)?
The most recent average sentiment score for ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ)?
The most recent sentiment for ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) is .
SEC-8K** Filing Available For ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.